Swiss Re says GLP-1 drugs could reduce US mortality by up to 6.4%
瑞士再保险股份(US:SSREY) Reuters·2025-09-17 17:27Reinsurance company Swiss Re said on Wednesday that widespread use of GLP-1 drugs to treat obesity could reduce the annual rate of death by up to 6.4% in the United States by 2045. ...